百大集团(600865) - 2024 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2024 was ¥37,633,259.43, a decrease of 17.04% compared to the same period last year[2]. - Net profit attributable to shareholders for Q3 2024 was ¥79,239,840.87, an increase of 61,923.90% year-on-year[2]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥22,530,045.50, down 30.20% from the previous year[2]. - The basic and diluted earnings per share for Q3 2024 were both ¥0.21, reflecting a year-on-year increase of 61,923.90%[4]. - Net profit for the third quarter of 2024 reached CNY 131,456,200.55, significantly up from CNY 20,670,484.36 in the same quarter of 2023, marking a growth of 535.5%[26]. - The net profit attributable to shareholders of the parent company for Q3 2024 was CNY 131,534,672.80, a significant increase from CNY 20,808,938.42 in Q3 2023, representing a growth of approximately 532.5%[27]. - The total comprehensive income for Q3 2024 reached CNY 133,513,724.53, compared to CNY 18,230,225.84 in Q3 2023, indicating a year-over-year increase of about 632.5%[27]. Cash Flow - The net cash flow from operating activities for the year-to-date was ¥19,883,025.74, a significant decrease of 61.98% compared to the previous year[2]. - The net cash flow from operating activities for the first three quarters of 2024 was CNY 19,883,025.74, a decrease of 62.0% compared to CNY 52,296,340.75 in the first three quarters of 2023[28]. - Cash inflows from operating activities for the first three quarters of 2024 were CNY 547,946,627.61, down 22.5% from CNY 706,639,524.35 in the same period of 2023[28]. - The net cash flow from investment activities for the first three quarters of 2024 was -CNY 59,498,463.56, contrasting with a positive CNY 36,795,365.57 in the first three quarters of 2023[29]. - The net cash flow from financing activities for the first three quarters of 2024 was -CNY 86,535,272.68, compared to -CNY 93,840,079.00 in the same period of 2023, showing a slight improvement[29]. Assets and Liabilities - Total assets at the end of the reporting period were ¥2,537,237,737.11, reflecting a slight increase of 0.07% from the end of the previous year[4]. - The company's total assets as of the end of the third quarter of 2024 were CNY 2,537,237,737.11, slightly up from CNY 2,535,540,425.34 at the end of 2023[24]. - Current liabilities decreased to CNY 162,119,692.23 from CNY 217,951,116.66, reflecting a reduction of 25.7%[24]. - Non-current liabilities totaled CNY 34,949,065.63, an increase from CNY 24,398,781.28, indicating a rise of 43.2%[24]. - The company's total equity attributable to shareholders increased to CNY 2,339,935,824.54 from CNY 2,292,878,900.44, representing a growth of 2.0%[24]. Investments - The company reported non-recurring gains of ¥66,745,264.58 from financial asset disposals and fair value changes[5]. - The company has invested RMB 6,000,000 in a private equity fund focused on healthcare technology, holding a 20% stake[17]. - The company has a remaining principal of RMB 3,987,600 yet to be recovered from its investment in the Huayangnian project[19]. - The company reported an investment income of 30.91 million RMB, mainly from increased trust income recovery[9]. - Investment income for the third quarter of 2024 was CNY 44,441,115.55, up from CNY 33,947,033.57 in the same period of 2023, showing an increase of 30.5%[26]. Shareholder Information - The company has a total of 14,572 common shareholders at the end of the reporting period[10]. - The largest shareholder, Xizi International Holdings Co., Ltd., holds 42.50% of the shares, totaling 159,921,566 shares[10]. Other Financial Metrics - The weighted average return on equity increased by 3.28 percentage points to 3.29% for the current period[4]. - Total operating revenue for the first three quarters of 2024 was CNY 142,491,407.16, a decrease of 6.3% compared to CNY 152,018,990.99 in the same period of 2023[25]. - Total operating costs for the third quarter of 2024 were CNY 72,403,090.42, down 8.8% from CNY 79,155,977.70 in the previous year[26]. - The company reported a significant increase in fair value gains, reaching CNY 46,897,724.54 compared to a loss of CNY 118,697,329.32 in the previous year[26]. - Deferred income tax liabilities rose to CNY 14,944,300.58 from CNY 1,094,592.59, indicating a substantial increase of 1265.5%[24].